References
1. Watkins SC, Williamson K, Davidson M, Donahue BS. Long-term mortality associated with acute kidney injury in children following congenital cardiac surgery. Paediatr Anaesth 2014;24:919–26.
2. Hassinger AB, Backer CL, Lane JC, Haymond S, Wang D, Wald EL. Predictive power of serum cystatin C to detect acute kidney injury and pediatricmodified RIFLE class in children undergoing cardiac surgery. Pediatr Crit Care Med 2012;13:435–40.
3. Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P. AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol 2015;10:554–61.
4. Finney H, Newman DJ, Price CP.Adult reference for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37:49–59.
5. Goldstein SL, Zappitelli M. Evaluation and Management of Acute Kidney Injury in Children. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric Nephrology, 7th edition. Springer‐Verlag Berlin Heidelberg, 2016:2139-67.
6. Ataei N, Bazargani B, Ameli S, Madani A, Javadilarijani F, Moghtaderi M. Early detection of acute kidney injury by serum cystatin C in critically ill children. Pediatr Nephrol 2014;29:133–8.
7. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571–90.
8. Akcan-Arikan A, Zappitelli M, Loftis LL.Modified RIFLE criteria incritically ill children with acute kidney injury. Kidney Int 2007; 71: 1028–35.
9. Herrero-Morin JD, Malaga S, Fernandez N. Cystatin C and β2-microglobulin: markers of glomerular filtration in critically ill children. Crit Care 2007; 11:59.
10. Safdar OY, Shalaby M, Khathlan N, Elattal B, Bin Joubah M, Bukahri E, Saber M, Alahadal A, Aljariry H, Gasim S, Hadadi A, Alqahtani A, Awleyakhan R, Kari JA. Serum cystatin is a useful marker for the diagnosis of acute kidney injury in critically ill children: prospectivecohort study. BMC Nephrol 2016;17(1):130.
11. Naik S, Sharma J, Yengkom R, Kalrao V, Mulay A. Acute kidney injury in critically ill children: risk factors and outcomes. Indian J Crit Care Med 2014;18:129–33.
12. Sadeghi-Bojd S, Noori NM, Mohammadi M, Teimouri A. Clinical characteristics and mortality risk prediction in children with acute kidney injury. Niger Med J 2015;56(5):327-32.
13. Jenssen GR, Hovland E, Bangstad HJ, Nygård K, Vold L, Bjerre A (2014): The incidence and aetiology of acute kidney injury in children in Norway between 1999 and 2008. Acta Paediatr;103(11):1192-7.
14. Franco M, Nishida SK, Sesso R. GFR Estimated From Cystatin C Versus Creatinine in Children Born Small for Gestational Age. Am J Kidney Dis 2008; 51:925-32.
15. Schanz M1, Pannes D, Dippon J, Wasser C, Alscher MD, Kimmel M. The Influence of Thyroid Function, Inflammation, and Obesity on Risk Prediction of Acute Kidney Injury by Cystatin C in the Emergency Department. Kidney Blood Press Res 2016;41(5):604-13.
16. Wang GN, Sun K, Hu DL, Wu HH, Wang XZ, Zhang JS. Serum cystatin C levels are associated with coronary artery disease and its severity. Clinical Biochemistry 2014; 47:176–81.
17. Volpon LC, Sugo EK, Carlotti AP. Diagnostic and prognostic value of serum cystatin C in critically ill children with acute kidney injury. Volpon LC1, Sugo EK, Carlotti AP. Pediatr Crit Care Med 2015;16(5):e125-31.
18. Lagos‑Arevalo P, Palijan A, Vertullo L (2015): Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine? Pediatr Nephrol;30: 665‑76.
19. Hamed HM, El-Sherbini SA, Barakat NA, Farid TM, Rasheed EA. Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children. Indian J Crit Care Med 2013;17(2):92-8.
20. Royakkers AA, Korevaar JC, van Suijlen JD, Hofstra LS, Kuiper MA, Spronk PE. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med;37:493–501.
DOI: https://dx.doi.org/10.18535/jmscr/v5i1.01
